Information for Physicians

St. Jude has a long history of developing innovative therapies for children with cancer. Phase I and Phase II clinical trials are necessary to define the toxicity and clinical pharmacology of potential anti-cancer agents to be used in future trials. St. Jude has a number of ongoing Phase I and Phase II studies available for children with malignancies that are recurrent, refractory to treatment, or for which no effective therapy exists.

To refer a patient or to obtain further information about Phase I or Phase II clinical trials for which your patient may be eligible, please contact us at or through our online form in the Related Topics box.

You may wish to refer to Parents: Why St. Jude? for assistance in answering your patient's questions.